Estimation of Apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: Apolipoprotein E gene is a "frailty gene", not a "longevity gene"
Genetic Epidemiology, 19:3, 202–210 (2000)
We developed a method to estimate genotype-specific average relative mortality risk, R, from genotype distributions in cross-sectional studies of people
belonging to different age-groups, and applied the method to new data from a study of apolipoprotein E genotypes (apoE) in 177 Danish centenarians and data
from a study of 40-year-old Danish men. Twenty-one percent of the centenarians were 2-carriers (genotypes 22 and 32) and 15% were 4-carriers (genotypes 44 and 43) compared to 13 and 29%, respectively, of the young men. The R-values were 0.95 (95% CI 0.88 to 1.02) for 2-carriers and 1.13 (95% CI 1.05 to 1.22) for 4-carriers, using 33- and 42 genotypes as reference. Corresponding values for 4-carriers were obtained by using published data from a French and a Finnish study of centenarians, whereas the values for 2-carriers were about 0.90 with these data. The method to estimate mortality risk and the results associate with the view that the apoE gene is a frailty gene. On the other hand, if odds ratios are used to summarize data from studies of this kind, they are more impressive and may propagate the misconception that apoE is a longevity gene. Genet. Epidemiol. 19:202-210, 2000. (© 2000 WILEY-LISS, INC.)